Palvella Therapeutics, Inc

Stock Chart, Company Information, and Scan Results

$97.40(as of Dec 9, 10:14 AM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Palvella Therapeutics, Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$97.40
Ticker SymbolPVLA
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees14
CountyUSA
Market Cap$1,189.4M
EBIDTAUnknown
10-Day Moving Average96.89
P/E Ratio-33.88
20-Day Moving Average91.00
Forward P/E Ratio0.00
50-Day Moving Average79.90
Earnings per Share-2.92
200-Day Moving Average44.14
Profit Margin-Infinity%
RSI64.27
Shares Outstanding11.8M
ATR6.58
52-Week High106.71
Volume177,042
52-Week Low11.17
Most Recent Support Level90.09
Book Value38.7M
Most Recent Resistance Level102.04
P/B Ratio28.86
Upper Keltner105.79
P/S RatioInfinity
Lower Keltner76.20
Debt-to-Equity Ratio105.79
Next Earnings DateUnknown
Cash Surplus53.3M
Next Ex-Dividend DateUnknown

Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product candidate is QTORIN 3.9% rapamycin anhydrous gel that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of other mTOR-driven skin diseases. The company is based in Wayne, Pennsylvania

Palvella Therapeutics, Inc In Our Stock Scanner

As of Dec 09, 2025
example chart graphic
Scan Name: Bullish PennantScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Uptrending StocksScan Type: Chart Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.